Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.82 | 2.2 |
NAV | ₹165.69 | ₹102.34 |
Fund Started | 20 Jul 2005 | 25 Mar 1997 |
Fund Size | ₹10159.11 Cr | ₹1072.74 Cr |
Exit Load | Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year. | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 27.71% | 28.35% |
3 Year | 19.07% | 26.27% |
5 Year | 20.90% | 25.03% |
1 Year
3 Year
5 Year
Equity | 98.79% | 99.31% |
Cash | 0.86% | 0.69% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.55% |
ICICI Bank Ltd. | 5.63% |
Infosys Ltd. | 5.44% |
Bharti Airtel Ltd. | 3.68% |
Axis Bank Ltd. | 3.24% |
State Bank of India | 3.04% |
Kotak Mahindra Bank Ltd. | 3.04% |
Tech Mahindra Ltd. | 3.03% |
Reliance Industries Ltd. | 2.80% |
Mahindra & Mahindra Ltd. | 2.41% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.21% |
Infosys Ltd. | 4.57% |
ICICI Bank Ltd. | 4.12% |
Dr. Reddy's Laboratories Ltd. | 3.14% |
State Bank of India | 2.74% |
NTPC Ltd. | 2.64% |
REC Ltd. | 2.49% |
Tech Mahindra Ltd. | 2.23% |
Amber Enterprises India Ltd. | 2.16% |
Suven Pharmaceuticals Ltd. | 2.07% |
Name | Amit Kumar Premchandani | Satish Ramanathan |
Start Date | 01 Feb 2018 | 01 Oct 2024 |
Name
Start Date
Description | The scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies across market capitalization spectrum. | The scheme aims to provide long term capital growth by investing primarily in a well-diversified portfolio of undervalued securities. |
Launch Date | 20 Jul 2005 | 25 Mar 1997 |
Description
Launch Date